Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/1991
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051936A Drythropoietin isoforms
06/05/1991CN1051934A Process for preparation of genelic vectors for nerve growth factor expression in eukaryotic cells
06/05/1991CA2070424A1 Method of treating septic shock
06/05/1991CA2004636A1 Externally-adjustable split stationary elastomer energized seal
06/04/1991US5021560 Glycoprotein extract from proteolysis of molluscan hemocyanin
06/04/1991US5021553 Anti-human adenocarcinoma antigen specific monoclonal antibody
06/04/1991US5021549 Physiologically active substances, probestin and prostatin and production thereof
06/04/1991US5021403 Antibiotic agents
06/04/1991US5021349 Culture medium containing human albumin, process for the preparation of an injectable product from this medium, product obtained and its use, and composition obtained
06/04/1991US5021341 Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
06/04/1991US5021340 Genetic engineering
06/04/1991US5021338 Enzyme extract from germinated sorghum for hydrolysis of protein material
06/04/1991CA1284625C Anti-human mesothelial cell monoclonal antibody
06/02/1991WO1991008301A1 PROTEINS PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS
06/02/1991WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991CA2070166A1 Proteins inhibiting the interaction between an immunoglobin fc fragment and its receptor, and their therapeutical use, especially in the treatment of hiv related ailments
06/02/1991CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding
05/1991
05/30/1991WO1991008294A1 Novel vaccine
05/30/1991WO1991008285A1 Production of recombinant human interleukin-1 inhibitor
05/30/1991WO1991007979A1 Chimeric proteins
05/30/1991WO1991007509A1 Localization and characterization of the wilms's tumor gene
05/30/1991WO1991007502A1 Methods and reagents to detect and characterize norwalk and related viruses
05/30/1991WO1991007495A1 A mammalian cytokine, il-11
05/30/1991WO1991007491A1 Non-glycosylated fgf-4 and compositions containing the same
05/30/1991WO1991007437A2 Improved cd-30 antibodies and fragments thereof
05/30/1991WO1991007423A1 Dna binding proteins including androgen receptor
05/30/1991WO1991007189A1 Conglutinin fragments, their production and use
05/30/1991CA2069622A1 Vaccine
05/30/1991CA2069106A1 Chimeric proteins
05/30/1991CA2030947A1 Process for the production of unfused protein in e. coli
05/29/1991WO1991008571A1 Storage device
05/29/1991WO1991007985A1 Monoclonal antibody which distinguishes helper inducer and supressor inducer ce4+ lymphocytes
05/29/1991EP0429242A2 Specific binding agents
05/29/1991EP0429162A1 Hydrolysis of amino bond of L-asparagine and reagent therefor
05/29/1991EP0428635A1 Heterologous block oligomers
05/29/1991EP0428615A1 Method for stabilizing heterologous protein expression and vectors for use therein
05/29/1991EP0428572A1 Producing commercially valuable polypeptides with genetically transformed endosperm tissue
05/29/1991DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation
05/29/1991CN1051757A Polypeptide compound and process for preparation thereof
05/28/1991WO1991008300A1 Process for the preparation of vancomycin
05/28/1991US5019648 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
05/28/1991US5019500 IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof
05/28/1991US5019499 Method of producing peptides by transforming myeloma cells with a recombinant plasmid
05/28/1991US5019386 Hepatitis B vaccine
05/28/1991US5019385 Novel lymphopine LK 2 and pharmaceutic compositions containing same
05/28/1991CA2045483A1 Process for the preparation of vancomycin
05/22/1991EP0428485A1 Novel antiidiotypic monoclonal antibodies
05/22/1991EP0428267A2 Erythropoietin isoforms
05/22/1991EP0428141A2 Hybrid promoter
05/22/1991EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor
05/22/1991CN1012645B Production of protein
05/21/1991WO1991007425A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/21/1991US5017692 Truncated human interleukin-a alpha
05/21/1991US5017495 Biosynthesis of p-cresol
05/21/1991US5017493 Ribosmoe binding site
05/21/1991US5017487 Genetic engineering
05/21/1991CA2068713A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
05/18/1991WO1991007500A1 Specific binding agents
05/18/1991WO1991007490A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991WO1991007481A1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin
05/18/1991CA2135744A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2068728A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2066670A1 Specific binding agents
05/16/1991WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/16/1991WO1991006861A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products
05/16/1991WO1991006668A1 Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
05/16/1991WO1991006667A1 Production of proteins using homologous recombination
05/16/1991WO1991006666A1 Production of proteins using homologous recombination
05/16/1991WO1991006658A2 Infective protein delivery system
05/16/1991WO1991006656A1 Promoter, expression vector and polypeptide synthesis
05/16/1991WO1991006655A1 E. coli secretory strains
05/16/1991WO1991006654A1 A method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991WO1991006653A1 Recombinant vaccine for porcine pleuropneumonia
05/16/1991WO1991006648A1 Glutamate receptor compositions and methods
05/16/1991WO1991006633A1 Differential diagnostic assay for brucellosis
05/16/1991WO1991006632A1 Inhibition of padgem-mediated cell binding
05/16/1991WO1991006574A1 A process for preparing peroxycarboxylic acids
05/16/1991WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
05/16/1991WO1991006570A1 HYBRID Fc RECEPTOR MOLECULES
05/16/1991WO1991006568A1 High molecular weight human angiogenic factors
05/16/1991WO1991006566A1 Novel compounds
05/16/1991WO1991006319A1 Methods and compositions for promoting immunopotentiation
05/16/1991WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
05/16/1991WO1990012879A3 Expression of human apolipoproteins ai-milano in yeast
05/16/1991CA2072657A1 Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms
05/16/1991CA2071478A1 Methods and compositions for promoting immunopotentiation
05/15/1991EP0427462A1 Process
05/15/1991EP0427399A1 Cancer marker and monoclonal antibodies specific therefor
05/15/1991EP0427296A1 Insulin precursors
05/15/1991EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them
05/15/1991EP0427162A1 Novel insulin derivatives, their preparation and use, and a pharmaceutical composition thereof
05/15/1991EP0427142A1 Antibiotic A/16686 recovery process
05/15/1991EP0427035A1 Protein overexpression in recombinant host cells
05/15/1991EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS
05/15/1991EP0426744A1 High efficiency translation of polycistronic messages in eucaryotic cells
05/15/1991CN1051394A Prepn. for series products of water soluble full component pearl powder
05/15/1991CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
05/15/1991CN1051389A Novel antibodies reactive with human carcinomas
05/15/1991CN1051302A Biologically active proteins and method for their prodn.
1 ... 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 ... 1125